Skip to main content
CVS
NYSE Trade & Services

CVS Health Expands GLP-1 Access with Lilly Collaboration and $29 MinuteClinic Visits

Tom Rudovsky · Reported by PR Newswire
More coverage: Consumer
Sentiment info
Positive
Importance info
8
Price
$104.82
Mkt Cap
$133.232B
52W Low
$61.35
52W High
$110.68
52W Position info
71% above low
Off High info
5.3% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CVS sits 71% above its 52-week low of $61.35.

Summary

CVS Health is revamping its weight management program to capture more of the booming GLP-1 market. The company is collaborating with Eli Lilly to offer Zepbound and Foundayo patients transparent pricing and app-based access by early Q4 2026, complementing existing Wegovy availability. MinuteClinic online weight loss visits are now $29 with no membership fee, making it the most affordable option and connecting patients to same-day pickup at 9,000 pharmacies. This builds on the June expansion of GLP-1 support and the May restoration of Zepbound coverage at Caremark, signaling an aggressive push to become a one-stop shop for weight loss care. The integrated model — combining telehealth, pharmacy, and pharmacist support — could drive foot traffic and prescription volume, strengthening CVS's competitive position against digital health rivals. With Medicare Advantage rates projected to rise over 5% for 2026 and the recent Omnicare sale closing, this consumer-focused initiative adds a growth lever amid ongoing legal and regulatory challenges.

Updates

  1. · Benzinga — Eligible commercially insured patients could pay as little as $25 per month for Zepbound or Foundayo, while uninsured may access medications for $149 via vouchers.

At the time of this announcement, CVS was trading at $104.82 on NYSE in the Trade & Services sector, with a market capitalization of approximately $133.2B. The 52-week trading range was $61.35 to $110.68. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CVS - Latest Insights

CVS
Nov 04, 2026, 1:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.13
Real-time Price: $80.00 info
Change: -$0.1287 (-0.16%) info
Market Cap: $102.064B info
CVS
Nov 04, 2026, 6:41 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $93.20
Real-time Price: $80.00 info
Change: -$13.20 (-14%) info
Market Cap: $102.064B info
CVS
Nov 04, 2026, 6:34 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $91.86
Real-time Price: $80.00 info
Change: -$11.86 (-13%) info
Market Cap: $102.064B info
CVS
Nov 04, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.49
Real-time Price: $80.00 info
Change: -$11.49 (-13%) info
Market Cap: $102.064B info
CVS
Nov 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.84
Real-time Price: $80.00 info
Change: -$11.84 (-13%) info
Market Cap: $102.064B info